Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)

31.08
Delayed Data
As of Aug 18
 +0.05 / +0.16%
Today’s Change
20.68
Today|||52-Week Range
40.83
+7.77%
Year-to-Date

Today’s Trading

Previous close31.03
Today’s open31.04
Day’s range30.87 - 31.40
Volume909,596
Average volume (3 months)1,535,890
Market cap$3.8B
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-43.56%
Earnings growth (this year)-9.83%
Earnings growth (next 5 years)+28.93%
Revenue growth (last year)+28,311.48%
P/E ratioNM
Price/Sales192.80
Price/Book7.28

Competitors

 Today’s
change
Today’s
% change
AKRXAkorn Inc-0.62-1.90%
AGNPRAAllergan plc-1.14-0.14%
MNKMallinckrodt Plc+0.03+0.08%
CLVSClovis Oncology Inc+2.09+2.99%
Data as of 4:01pm ET, 08/18/2017

Financials

Next reporting dateNovember 6, 2017
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$17.3M
Annual profit (last year)-$271.4M
Net profit margin-1,565.94%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen R. Davis
Vice President-Technology Development &
Operations
James A. Nash
Corporate headquarters
San Diego, California

Forecasts